Of chloroquine and COVID-19

0 avis

Of chloroquine and COVID-19

Archive ouverte

International audience. Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model

Archive ouverte | Cochin, Maxime | CCSD

International audience. Late 2020, SARS-CoV-2 Alpha variant emerged in United Kingdom and gradually replaced G614 strains initially involved in the global spread of the pandemic. In this study, we use a Syrian hamst...

Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg

Archive ouverte | Touret, Franck | CCSD

International audience

Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?

Archive ouverte | Pastorino, Boris | CCSD

International audience. Standard precautions to minimize the risk of SARS-CoV-2 transmission implies that infected cell cultures and clinical specimens may undergo some sort of inactivation to reduce or abolish infe...

Chargement des enrichissements...